TipRanks on MSN13h
Option Care Health’s Earnings Call: Growth Amid Challenges
Option Care Health Inc (($OPCH)) has held its Q4 earnings call. Read on for the main highlights of the call. Option Care Health Inc. recently held ...
Managed Healthcare Executive20h
MedImpact Adds the Biosimilars Selarsdi and Yesintek to Formulary
Simlandi and adalimumab-adaz have been with on formulary, along with Humira, beginning Jan. 1, 2025, Arpit Patel, Pharm.D., ...
Managed Healthcare Executive23h
BC of Michigan Adds — and Drops — Step Edits for Darzalex Faspro
Blue Cross Blue Shield of Michigan said it is evaluating any potential updates to the coverage process for Darzalex Faspro ...